Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
Oral Diseases|January 4, 2018
P2Y2 R deletion ameliorates sialadenitis in IL-14α-transgenic miceL T Woods, J M Camden, M G Khalafalla, et al.
American Journal of Hematology|January 1, 1979
Inhibitors of fibrinolysis in diabetic children, mothers, and their newbornC M Ambrus, J L Ambrus, N Courey, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1983
In vivo safety of hollow fiber enzyme-reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuriaC M Ambrus, S D Sharma, C Horváth, et al.
Journal of Medicinal Chemistry|November 1, 1985
Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agentsJ E MacDiarmid, W C Rose, W C Biddle, et al.
Research Communications in Chemical Pathology and Pharmacology|July 1, 1982
Depletion of phenylalanine in the blood of phenylketonuric patients using a PAL-enzyme reactor. An in vitro studyC M Ambrus, C Horváth, K Kalghatgi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1993
Identification of a cDNA for a human high-molecular-weight B-cell growth factorJ L Ambrus, J Pippin, A Joseph, et al.
Annals of Internal Medicine|April 1, 1987
Extracorporeal enzyme reactors for depletion of phenylalanine in phenylketonuriaC M Ambrus, S Anthone, C Horvath, et al.
Pageof 25